Please E-mail suggested additions, comments and/or corrections to Kent@MoreLaw.Com.
Help support the publication of case reports on MoreLaw
Pharmacychecker.com, LLC v. Legitscript, LLC
Date: 05-28-2025
Case Number: 22-CV-252
Judge: Michael H. Simon
Court: Untied States District Court for the District Oregon (Multnomah County)
Plaintiff's Attorney: Aaron Gott, Phillip Van Der Weele
Defendant's Attorney: Richard Sybert and Holly L.K. Heffner
Description:
Portland, Oregon civil litigation lawyers represented the parties in an anti-trust violation theory.
Two wrongs don't make a right. Nor do they necessarily
cancel each other out. In this case, PharmacyChecker.com
LLC ("PharmacyCheckerâ€) sued its competitor LegitScript
LLC ("LegitScriptâ€) for engaging in a group boycott in
violation of antitrust laws. LegitScript moved for summary
judgment, contending that PharmacyChecker lacked
antitrust standing because PharmacyChecker's business
facilitated illegal activities and, accordingly, it could not
suffer any legally cognizable injury under Section 4 of the
Clayton Act. The district court denied LegitScript's motion
and certified an interlocutory appeal under 28 U.S.C.
§ 1292(b). We affirm. Following the Supreme Court's
teachings and the precedents in this Circuit, we must hold
that, to further the public policy in favor of vigorous antitrust
enforcement, a plaintiff may have antitrust standing under
Section 4 of the Clayton Act to sue for injuries suffered by
its business or property interest when competing in a
legitimate market, even if such business or property interest
has been attained by unlawful means.
I.
A.1
The Federal Food, Drug, and Cosmetic Act ("FFDCAâ€)
prohibits the "introduction or delivery for introduction into
PHARMACYCHECKER . COM LLC V. L EGIT SCRIPT LLC 5
interstate commerce†of any drug that is adulterated,
misbranded, or not approved by the Food and Drug
Administration ("FDAâ€). 21 U.S.C. §§ 331(a), 331(d),
355(a); see also In re Canadian Imp. Antitrust Litig., 470
F.3d 785, 788–89 (8th Cir. 2006) (noting that personal
importation of foreign drugs into the United States can
violate the FFDCA either "because the drugs are not
approved in accordance with 21 U.S.C. § 355, are not
labeled as required by 21 U.S.C. § 352, or are dispensed
without a valid prescription in contravention of 21 U.S.C.
§ 353(b)(1)â€).
It is illegal in "most circumstances†"for individuals to
import drugs†into the United States "for personal use
because these products purchased from other countries often
have not been approved by the FDA for use and sale in†the
United States. Personal Importation, U.S. FOOD & DRUG
ADMIN., https://www.fda.gov/industry/import-
basics/personal-importation (last updated Oct. 8, 2024). The
FDA "may consider a more permissive decision†in
"allowing the importation of medications for personal useâ€
if, for instance, the drug "is not for treatment of a serious
condition and there is no known significant health risk,†or
if the drug "is for a serious condition for which effective
treatment may not be available domestically either through
commercial or clinical means.†Id. And foreign nationals
who vacation, study, or work in the United States may also
ship to themselves as much as a 90-day supply of drugs for
personal use; if they stay in the United States for more than
90 days, they may have additional medications shipped to
them.2 Id.
Against this backdrop, PharmacyChecker operates the
PharmacyChecker.com website. The website is not a
pharmacy; it does not "buy, sell, distribute, dispense, or
process orders for†any drugs. Rather, it accredits online
pharmacies across the globe for their safety standards, and it
compares the prices of the drugs offered by those pharmacies
for its website users from around the world. According to
PharmacyChecker, its "central objective has been to
examine the qualifications (i.e., practice and safety
standards) of online pharmacies wherever they might be to
provide worldwide visitors with information to make good
choices, to be safe, and to get medication most affordably.â€
PharmacyChecker's business model depends on
charging online pharmacies verification fees and click-
through fees. 3 From January 2015 through August 2021
("Relevant Periodâ€), approximately 14% of
PharmacyChecker's revenue came from verification fees,
which were charged to online pharmacies for services that
PharmacyChecker provided in accrediting those pharmacies
and listing them on its website. About 84% of the
verification fees that PharmacyChecker collected were paid
by foreign pharmacies.
In the Relevant Period, approximately 85% of
PharmacyChecker's revenue came from click-through fees,
which PharmacyChecker charged its accredited pharmacies
whenever their hyperlinks on the PharmacyChecker.com
website were clicked. About 95% of PharmacyChecker's
click-through revenue in the Relevant Period came from
online pharmacies located outside the United States;
approximately 69% of that revenue resulted from clicks
made by PharmacyChecker.com users located inside the
United States. This means around 56% of
PharmacyChecker's total revenue in the Relevant Period
was generated from clicks made by PharmacyChecker.com
users inside the United States on hyperlinks for online
pharmacies outside the United States.
These click-through fees were charged to the pharmacies
solely based on the clicks made by PharmacyChecker.com
users. PharmacyChecker collected these fees irrespective of
whether its users ended up purchasing any drugs.
Accordingly, PharmacyChecker did not track its website
users' activities after they clicked through to those
pharmacies' websites and did not know how many of its U.S.
users purchased drugs from foreign pharmacies and had
them shipped into the United States. On this point, the
record consists of one online pharmacy's deposition
testimony that only about 3.47% of the clicks from
PharmacyChecker.com resulted in a drug transaction.
Two wrongs don't make a right. Nor do they necessarily
cancel each other out. In this case, PharmacyChecker.com
LLC ("PharmacyCheckerâ€) sued its competitor LegitScript
LLC ("LegitScriptâ€) for engaging in a group boycott in
violation of antitrust laws. LegitScript moved for summary
judgment, contending that PharmacyChecker lacked
antitrust standing because PharmacyChecker's business
facilitated illegal activities and, accordingly, it could not
suffer any legally cognizable injury under Section 4 of the
Clayton Act. The district court denied LegitScript's motion
and certified an interlocutory appeal under 28 U.S.C.
§ 1292(b). We affirm. Following the Supreme Court's
teachings and the precedents in this Circuit, we must hold
that, to further the public policy in favor of vigorous antitrust
enforcement, a plaintiff may have antitrust standing under
Section 4 of the Clayton Act to sue for injuries suffered by
its business or property interest when competing in a
legitimate market, even if such business or property interest
has been attained by unlawful means.
I.
A.1
The Federal Food, Drug, and Cosmetic Act ("FFDCAâ€)
prohibits the "introduction or delivery for introduction into
PHARMACYCHECKER . COM LLC V. L EGIT SCRIPT LLC 5
interstate commerce†of any drug that is adulterated,
misbranded, or not approved by the Food and Drug
Administration ("FDAâ€). 21 U.S.C. §§ 331(a), 331(d),
355(a); see also In re Canadian Imp. Antitrust Litig., 470
F.3d 785, 788–89 (8th Cir. 2006) (noting that personal
importation of foreign drugs into the United States can
violate the FFDCA either "because the drugs are not
approved in accordance with 21 U.S.C. § 355, are not
labeled as required by 21 U.S.C. § 352, or are dispensed
without a valid prescription in contravention of 21 U.S.C.
§ 353(b)(1)â€).
It is illegal in "most circumstances†"for individuals to
import drugs†into the United States "for personal use
because these products purchased from other countries often
have not been approved by the FDA for use and sale in†the
United States. Personal Importation, U.S. FOOD & DRUG
ADMIN., https://www.fda.gov/industry/import-
basics/personal-importation (last updated Oct. 8, 2024). The
FDA "may consider a more permissive decision†in
"allowing the importation of medications for personal useâ€
if, for instance, the drug "is not for treatment of a serious
condition and there is no known significant health risk,†or
if the drug "is for a serious condition for which effective
treatment may not be available domestically either through
commercial or clinical means.†Id. And foreign nationals
who vacation, study, or work in the United States may also
ship to themselves as much as a 90-day supply of drugs for
personal use; if they stay in the United States for more than
90 days, they may have additional medications shipped to
them.2 Id.
Against this backdrop, PharmacyChecker operates the
PharmacyChecker.com website. The website is not a
pharmacy; it does not "buy, sell, distribute, dispense, or
process orders for†any drugs. Rather, it accredits online
pharmacies across the globe for their safety standards, and it
compares the prices of the drugs offered by those pharmacies
for its website users from around the world. According to
PharmacyChecker, its "central objective has been to
examine the qualifications (i.e., practice and safety
standards) of online pharmacies wherever they might be to
provide worldwide visitors with information to make good
choices, to be safe, and to get medication most affordably.â€
PharmacyChecker's business model depends on
charging online pharmacies verification fees and click-
through fees. 3 From January 2015 through August 2021
("Relevant Periodâ€), approximately 14% of
PharmacyChecker's revenue came from verification fees,
which were charged to online pharmacies for services that
PharmacyChecker provided in accrediting those pharmacies
and listing them on its website. About 84% of the
verification fees that PharmacyChecker collected were paid
by foreign pharmacies.
In the Relevant Period, approximately 85% of
PharmacyChecker's revenue came from click-through fees,
which PharmacyChecker charged its accredited pharmacies
whenever their hyperlinks on the PharmacyChecker.com
website were clicked. About 95% of PharmacyChecker's
click-through revenue in the Relevant Period came from
online pharmacies located outside the United States;
approximately 69% of that revenue resulted from clicks
made by PharmacyChecker.com users located inside the
United States. This means around 56% of
PharmacyChecker's total revenue in the Relevant Period
was generated from clicks made by PharmacyChecker.com
users inside the United States on hyperlinks for online
pharmacies outside the United States.
These click-through fees were charged to the pharmacies
solely based on the clicks made by PharmacyChecker.com
users. PharmacyChecker collected these fees irrespective of
whether its users ended up purchasing any drugs.
Accordingly, PharmacyChecker did not track its website
users' activities after they clicked through to those
pharmacies' websites and did not know how many of its U.S.
users purchased drugs from foreign pharmacies and had
them shipped into the United States. On this point, the
record consists of one online pharmacy's deposition
testimony that only about 3.47% of the clicks from
PharmacyChecker.com resulted in a drug transaction.
Outcome:
Affirmed
Plaintiff's Experts:
Defendant's Experts:
Comments:
About This Case
What was the outcome of Pharmacychecker.com, LLC v. Legitscript, LLC?
The outcome was: Affirmed
Which court heard Pharmacychecker.com, LLC v. Legitscript, LLC?
This case was heard in Untied States District Court for the District Oregon (Multnomah County), OR. The presiding judge was Michael H. Simon.
Who were the attorneys in Pharmacychecker.com, LLC v. Legitscript, LLC?
Plaintiff's attorney: Aaron Gott, Phillip Van Der Weele. Defendant's attorney: Richard Sybert and Holly L.K. Heffner.
When was Pharmacychecker.com, LLC v. Legitscript, LLC decided?
This case was decided on May 28, 2025.